The Washington Post reports today on a lawsuit filed by six scientists at the Food and Drug Administration who blew the whistle on what they believe were dangerous medical devices their bosses pressed them to approve.


The new twist in their case: The FDA monitored the whistleblowers’ personal e-mails as they communicated with each other and congressional staff about their concerns.

See the story and accompanying sample of the monitored e-mails here.